{{Rsnum
|rsid=1042113
|Gene=SLC1A2
|Chromosome=11
|position=35286822
|Orientation=minus
|GMAF=0.2691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC1A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 36.3 | 7.1
| HCB | 61.3 | 33.6 | 5.1
| JPT | 42.0 | 51.8 | 6.2
| YRI | 49.7 | 44.2 | 6.1
| ASW | 57.9 | 35.1 | 7.0
| CHB | 61.3 | 33.6 | 5.1
| CHD | 65.1 | 29.4 | 5.5
| GIH | 87.1 | 12.9 | 0.0
| LWK | 37.3 | 50.9 | 11.8
| MEX | 50.0 | 37.9 | 12.1
| MKK | 32.1 | 50.0 | 17.9
| TSI | 63.4 | 30.7 | 5.9
| HapMapRevision=28
}}Association study of polymorphisms in the excitatory amino acid transporter 2 gene ([[SLC1A2]]) with [[schizophrenia]].{{PMID|15296513|OA=1
}}

Usefulness of direct sequencing of pooled DNA for SNP identification and allele-frequency determination compatible with a common disease/common variant hypothesis.{{PMID|20449810}}

[http://bbs.neuro.or.kr/space/journal/2010/201002002.pdf Publicly Available Single Nucleotide Polymorphisms in Genes Possibly Susceptible to Antiepileptic Drug Resistance in Healthy Koreans]

Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of [[amyotrophic lateral sclerosis]].{{PMID|18852346}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}